Loading...
Docoh

Seelos Therapeutics (SEEL)

Utility
Treatment of Protein Aggregation Myopathic and Neurodegenerative Diseases by Parenteral Administration of Trehalose
21 Apr 22
Disclosed is a method of treatment of a disease associated with abnormal protein aggregation comprising parenterally administering pharmaceutical formulations comprising trehalose.
Dalia Megiddo
Filed: 23 Jun 21
Utility
Compositions and Methods for Treating an Aggregation Disease or Disorder
14 Jan 21
The present invention alleviates a sign or symptom of an aggregation disease or disorder by administering an aqueous formulation comprising trehalose.
Dalia Megiddo
Filed: 15 Jul 20
Utility
Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose
21 Dec 20
Disclosed is a method of treatment of a disease associated with abnormal protein aggregation comprising parenterally administering pharmaceutical formulations comprising trehalose.
Dalia Megiddo
Filed: 1 Jul 19
Utility
Compositions and methods for treating an aggregation disease or disorder
24 Aug 20
The present invention alleviates a sign or symptom of an aggregation disease or disorder by administering an aqueous formulation comprising trehalose.
Dalia Megiddo
Filed: 30 Jan 19
Utility
Treatment of Protein Aggregation Myopathic and Neurodegenerative Diseases by Parenteral Administration of Trehalose
11 Dec 19
Disclosed is a method of treatment of a disease associated with abnormal protein aggregation comprising parenterally administering pharmaceutical formulations comprising trehalose.
Dalia Megiddo
Filed: 1 Jul 19
Utility
Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose
2 Dec 19
Disclosed is a method of treatment of a disease associated with abnormal protein aggregation comprising parenterally administering pharmaceutical formulations comprising trehalose.
Dalia Megiddo
Filed: 6 May 14
Utility
Compositions and Methods for Treating an Aggregation Disease or Disorder
6 Nov 19
The present invention alleviates a sign or symptom of an aggregation disease or disorder by administering an aqueous formulation comprising trehalose.
Dalia MEGIDDO
Filed: 30 Jan 19
  • 1
Patents are sorted by USPTO publication date, most recent first